淋巴系统功能障碍及其对发作严重程度,认知功能和情感症状的影响,仅在患有泛性强度-克隆性发作的患者中
Qibing Sun1, Jinshuai Liu1, Zifan Yang1
1Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
Journal of the neurological sciences
|May 11, 2025
概括
淋巴系统 (GS) 功能受到损害,仅在泛性强力-克隆性发作 (单独GTCS) 时,通过较低的周周血管空间 (ALPS) 指数进行分析. 这种成像生物标志物与发作严重程度和认知障碍相关.
科学领域:
- 神经科学是一个神经科学.
- 放射学 放射学是一门学科.
- 发病学 (Epileptology) 是一个专业的学科.
背景情况:
- 仅仅泛性强力-克隆性发作 (单独GTCS) 构成一个独特的综合征.
- 淋巴系统 (GS) 功能障碍,这是大脑清除途径,与病原发生有关.
研究的目的:
- 为了评估单独GTCS患者的GS功能,使用来自扩散光谱成像 (DSI) 的周周血管空间 (ALPS) 指数进行分析.
- 仅在GTCS中,探索ALPS指数与临床,认知和情绪测量之间的关联.
主要方法:
- 扩散光谱成像 (DSI) 对101名单独使用GTCS的患者和76名健康对照进行.
- 计算了ALPS指数,并与发作严重程度 (NHS3),性释放指数 (EDI),认知功能 (MoCA),耻辱感 (KSSE) 和抑郁 (HAMD) 分数相关联.
主要成果:
- 与对照组相比,仅使用GTCS治疗的患者的ALPS指数明显较低 (1.43对1.52,p < 0.01).
- ALPS指数与认知功能 (MoCA) 有正相关,与年龄,发作严重程度 (NHS3),耻辱感 (KSSE) 和抑郁症 (HAMD) 有负相关.
- 在患有较高抗发作药物负载和高EDI值的患者中观察到较低的ALPS指数.
结论:
- 仅在GTCS中,淋巴系统功能就会受到损害,这可以通过降低ALPS指数来证明.
- 仅在GTCS中,ALPS指数作为潜在的非侵入性成像生物标志物用于疾病负担.
- ALPS指数可能为单独的GTCS及其并发症背后的病理生理机制提供新的见解.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
260
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
260
Arteries of the Lower Limbs
166
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
166
Seizures: Classification
284
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
284
Antiepileptic Drugs: Potassium Channel Activators
126
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
126
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
187
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
187
Antiepileptic Drugs: Glutamate Antagonists
249
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
249


